Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

HIV/AIDS

People taking HIV drugs rises to almost 16 million, UNAIDs reports

UN agency predicts people with access to ARV treatment could double by 2020.

The number of people receiving HIV treatment reached 15.8 million in June 2015, up 2.2 million on the previous year, says a new report by UNAIDS. In the image, Michel Sibidé, executive director of UNAIDS

Source: John Zarocostas

Michel Sibidé, the executive director of UNAIDS, says their report shows that every five years the world has been able to double the number of people on HIV treatment

The number of people receiving HIV treatment reached 15.8 million in June 2015, an increase of 2.2 million on the previous year, says a new report by UNAIDS.

The UN agency predicts that doubling the number of people with access to antiretroviral (ARV) therapy by 2020 could help break the global AIDS epidemic.

“The report is showing that every five years we have been able to double the number of people on treatment, which is amazing,” Michel Sibidé, executive director of UNAIDS, said at a news conference to launch the report ahead of World AIDS Day on 1 December 2015. “If we manage to sustain our investments, and make sure that we double the number of people on treatment, we can break the backbone of this epidemic.”

Medical aid group Doctors Without Borders lauded the advances in the pace of HIV treatment scale-up, but cautions that “to achieve the global goal of reaching 30 million people with treatment by 2020, we’re going to need to see 3 million new people on treatment each year”.

“Countries should waste no time and take up new World Health Organization guidelines that call for all people living with HIV to be offered immediate treatment,” a spokesperson says.

In 2010, 7.5 million people were accessing ARV treatment, compared with 2.2 million people in 2005.

Sibidé also signalled that he would announce a breakthrough in lower prices for second-line ARVs. “We have been able to break the trajectory of this cost for first-line [ARVs], and I hope very soon we will be able to announce reduction for best second-line [ARVs],” he said. “That reduction will help millions of people.”

The agency estimates that at the end of 2014, 36.9 million people were living with HIV, 2.0 million were newly infected and 1.2 million died of AIDS-related illnesses.

The UNAIDS report, ‘On the fast-track to end AIDS by 2030: focus on location and population’, estimates that 41% of all adults living with HIV were accessing treatment in 2014, up from 23% in 2010, and that in the same period, 32% of children with HIV were receiving treatment, up from 14% in 2010.

But regional data show a wide variation in access to treatment. In 2014, treatment coverage of all adults aged over 15 years and living with HIV in eastern Europe and Central Asia was only 18%, and even lower at 14% in the Middle East and North Africa. Access was better in sub-Saharan Africa, the most endemic region, with 41% coverage (36% men; 47% women), and in the Asia-Pacific region and Latin America, with 36% and 47% coverage, respectively.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20200176

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Pathology and Therapeutics for Pharmacists

    Pathology and Therapeutics for Pharmacists

    An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.

    £54.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • The number of people receiving HIV treatment reached 15.8 million in June 2015, up 2.2 million on the previous year, says a new report by UNAIDS. In the image, Michel Sibidé, executive director of UNAIDS

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.